Table 2.

Summary of the reported cases with rituximab treatment for GBS.

References	Age	Gender	Causes of GBS	Clinical features	GBS therapy	Outcome
Gu et al. (17)	49	Female	Ipilimumab 3 mg/kg Nivolumab 1 mg/kg	Weakness and pain of the 4 limbs Sensory loss	(1) IVIg and steroids (2) Steroids, plasma exchange, mycophenolate, and rituximab	Significant improvement in nerve and muscle strength
Janssen et al. (3)	74	Male	Ipilimumab 10 mg/kg q3w	Tetraparesis Distal hypoesthesia of the 4 limbs Diffuse areflexia	(1) Steroids (2) IVIg and Infliximab (3) Plasmapheresis (4) IVIg and rituximab	Fatal due to respiratory failure/pneumonia
Beshir et al. (18)	69	Male	Systemic lupus erythematosus	Severe generalized weakness diplopia and swallowing difficulty	(1) IVIg and steroids (2) rituximab plasma exchange	No motor deficit Intermittent paraesthesia of the 4 limbs
Reddy (19)	9	Female	Systemic lupus erythematosus	Weakness and pain of the 4 limbs Sensory loss	(1) IVIg and steroids (2) rituximab	Full recovery
Ostronoff et al. (8)	58	Male	Allogeneic hematopoietic SCT	Weakness and pain of the 4 limbs Facial palsy	(1) IVIg (2) rituximab	Significant muscle strength recovery